Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
Sánchez-Muñoz A, Román-Jobacho A, Pérez-Villa L, Sánchez-Rovira P, Miramón J, Pérez D, Sáez MI, de Luque V, Medina L, Ramírez-Tortosa CL, Vicioso L, Medina JA, Ribelles N, Alba E. Sánchez-Muñoz A, et al. Among authors: vicioso l. Oncology. 2012;83(4):228-33. doi: 10.1159/000341537. Epub 2012 Aug 16. Oncology. 2012. PMID: 22907070
A microRNA signature associated with early recurrence in breast cancer.
Pérez-Rivas LG, Jerez JM, Carmona R, de Luque V, Vicioso L, Claros MG, Viguera E, Pajares B, Sánchez A, Ribelles N, Alba E, Lozano J. Pérez-Rivas LG, et al. Among authors: vicioso l. PLoS One. 2014 Mar 14;9(3):e91884. doi: 10.1371/journal.pone.0091884. eCollection 2014. PLoS One. 2014. PMID: 24632820 Free PMC article.
Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.
Rueda A, Olmos D, Vicioso L, Quero C, Gallego E, Pajares-Hachero BI, Mendiola M, Casanova M, Álvarez M, Provencio M, Alba E. Rueda A, et al. Among authors: vicioso l. Leuk Lymphoma. 2015 May;56(5):1286-94. doi: 10.3109/10428194.2014.952227. Epub 2015 Feb 7. Leuk Lymphoma. 2015. PMID: 25098430
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.
Sánchez-Muñoz A, Vicioso L, Santonja A, Álvarez M, Plata-Fernández Y, Miramón J, Zarcos I, Ramírez-Tortosa CL, Montes-Torres J, Jerez JM, de Luque V, Llácer C, Fernández-De Sousa CE, Pérez-Villa L, Alba E. Sánchez-Muñoz A, et al. Among authors: vicioso l. Mod Pathol. 2018 Feb;31(2):299-306. doi: 10.1038/modpathol.2017.129. Epub 2017 Oct 6. Mod Pathol. 2018. PMID: 28984296 Free article.
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy.
Santonja A, Sánchez-Muñoz A, Lluch A, Chica-Parrado MR, Albanell J, Chacón JI, Antolín S, Jerez JM, de la Haba J, de Luque V, Fernández-De Sousa CE, Vicioso L, Plata Y, Ramírez-Tortosa CL, Álvarez M, Llácer C, Zarcos-Pedrinaci I, Carrasco E, Caballero R, Martín M, Alba E. Santonja A, et al. Among authors: vicioso l. Oncotarget. 2018 May 29;9(41):26406-26416. doi: 10.18632/oncotarget.25413. eCollection 2018 May 29. Oncotarget. 2018. PMID: 29899867 Free PMC article.
38 results